VC firm

Abingworth

4 investors · 4 verified

Here are all investors at Abingworth.

Investor preview

emails unlock with a plan

Investors on this list. Email addresses unlock with a plan.
namefirmemaillocationverified
Kurt von EmsterManaging PartnerAbingworthUnited States3w ago
Jacqueline GrantPrincipalAbingworthUnited States3w ago
Andrew SinclairPartnerAbingworthUnited Kingdom4w ago
Genghis Lloyd-HarrisPartnerAbingworthUnited Kingdom4w ago

Browse all VCs

Recent investments at Abingworth

  • Cytospire TherapeuticsSeries A · $83M · 2026
  • R1 TherapeuticsSeries A · $78M · 2026
  • Addition TherapeuticsSeries A · $100M · 2025
  • IambicSeries Unknown · $130M · 2025
  • WugenSeries C · $120M · 2025
  • GlycomineSeries C · $120M · 2025
  • Atsena TherapeuticsSeries C · $150M · 2025
  • AdvanCellSeries C · $110M · 2025
  • Ascend Gene & Cell TherapiesSeries A · $66M · 2023
  • Entact BioSeries A · $81M · 2022
  • Launch TherapeuticsPrivate Equity · 2022
  • Anjarium BiosciencesSeries A · $60M · 2021

What founders say

4.1Based on 11 reviews
Abingworth investors - emails & contacts | Mintround